Pulmonary Diffusing Capacity for Nitric Oxide¶
A pulmonary-function measure of nitric-oxide uptake from alveolar gas into pulmonary capillary blood, weighted toward alveolar–capillary membrane conductance and often paired with carbon-monoxide diffusing capacity to partition gas-transfer resistance.
Core Idea¶
Pulmonary Diffusing Capacity for Nitric Oxide, abbreviated DLNO or TLNO, quantifies how rapidly inhaled nitric oxide moves from alveolar gas into pulmonary capillary blood per unit driving pressure. Because nitric oxide reacts with hemoglobin far more rapidly than carbon monoxide, its measured uptake is comparatively weighted toward conductance across the alveolar–capillary membrane. The measure is therefore useful both as a standardized pulmonary-function result and, when obtained with DLCO, as evidence for partitioning membrane and blood components of lung gas transfer.
Scope of Application¶
DLNO applies wherever a standardized pulmonary-function maneuver measures disappearance of inhaled nitric oxide from alveolar gas and reports uptake per effective pressure difference under a declared protocol and reference system. - Clinical pulmonary-function laboratories. DLNO can accompany routine gas-transfer assessment when approved equipment, trained operators, quality control, and an applicable reference equation are available. - Respiratory-physiology laboratories. Controlled studies use the measurement to investigate alveolar-to-capillary gas transfer and its membrane and blood-phase contributions. - Combined single-breath DLNO–DLCO testing. Simultaneous nitric-oxide and carbon-monoxide uptake permits direct reporting of both capacities and their ratio from one maneuver. - Membrane–microvascular partition studies. Paired measurements support model-dependent estimates of membrane diffusing capacity and pulmonary capillary blood volume under declared Roughton–Forster assumptions.
Clarity¶
A clear report states whether the symbol means diffusing capacity or transfer factor, gives conventional or SI units, names the technical standard, and distinguishes measured quantities from modeled components. A low DLNO is an observation; attributing it specifically to membrane thickening requires additional evidence. Joint interpretation should state the assumed NO–hemoglobin reaction rate and any fixed ratio used to solve for membrane conductance and capillary blood volume.
Manages Complexity¶
DLNO compresses a rapid multistep path—ventilation, alveolar mixing, membrane transfer, plasma diffusion, and hemoglobin reaction—into uptake per effective alveolar-to-blood pressure difference. The analyst tracks the maneuver and breath-hold time, inspired and expired concentrations, alveolar volume, analyzer and calibration, units, hemoglobin and altitude corrections, and reference equation. Those coordinates make a result readable as within or below its reference range and comparable across repeated tests when protocol and device remain compatible.
Abstract Reasoning¶
Reasoning begins with resistances in series. Overall gas transfer reflects membrane and blood components, but nitric oxide and carbon monoxide weight those components differently. Two suitably independent measurements can therefore constrain otherwise entangled physiological contributions. A valid counterfactual asks which component should alter DLNO more than DLCO, while recognizing that real disease may change several components simultaneously. The measurement supports decomposition; it does not guarantee unique causal inference.
Knowledge Transfer¶
Within respiratory physiology and pulmonary-function testing, DLNO transfers across laboratories, reference studies, exercise protocols, and longitudinal testing when the maneuver, calibration, units, corrections, and interpretive model remain compatible. What carries is nitric-oxide uptake per effective alveolar-to-blood pressure difference, the breath-hold and concentration measurements, acceptability criteria, alveolar-volume context, corrections, and the distinction between observed DLNO and modeled membrane or capillary components. Other tracer methods share the measurement-and-model mechanism, but nitric oxide, alveoli, capillary blood, hemoglobin kinetics, and pulmonary reference equations remain home-bound. Outside compatible lung gas exchange, the name stops; joint probes also cannot identify a unique lesion without further evidence.
Relationships to Other Abstractions¶
Current abstraction Pulmonary Diffusing Capacity for Nitric Oxide Domain-specific
Parents (1) — more general patterns this builds on
-
Pulmonary Diffusing Capacity for Nitric Oxide is a kind of Measurement Prime
The target attribute is nitric-oxide transfer from alveolar gas into pulmonary capillary blood; the scale is transfer rate per effective driving pressure in declared conventional or SI units.
Hierarchy path (1) — routes to 1 parentless root
- Pulmonary Diffusing Capacity for Nitric Oxide → Measurement
Neighborhood in Abstraction Space¶
Pulmonary Diffusing Capacity for Nitric Oxide sits in a sparse region of the domain-specific corpus (89th percentile for distinctiveness): few abstractions share its structure, so a faithful description tends to retrieve it precisely.
Family — Unclustered & Miscellaneous (2551 abstractions)
Nearest neighbors
- Rapid Shallow Breathing Index — 0.82
- Body Fluid to Serum Concentration Ratio — 0.82
- Helium dilution technique — 0.81
- Bronchoalveolar lavage — 0.80
- Thyroid hormone binding ratio — 0.79
Computed from structural-signature embeddings · 2026-10-08